Literature DB >> 11861043

Ovarian hormones induce TGF-beta(3) and fibronectin mRNAs but exhibit a disparate action on cardiac fibroblast proliferation.

Isabelle Mercier1, Federico Colombo, Sylvie Mader, Angelino Calderone.   

Abstract

UNLABELLED: Prior to menopause, women have a lower risk of cardiovascular disease compared to age-matched men. Despite the well-documented beneficial physiological effects of ovarian hormones on vascular reactivity and growth, very little is known with regard to the direct action on cardiac cells.
OBJECTIVE: The following study examined the pattern of ovarian hormone receptor subtype expression in cardiac fibroblasts, the modulator role of 17 beta-estradiol and progesterone on growth and their respective influence on putative molecular events of extracellular matrix remodeling. METHODS AND
RESULTS: Neonatal rat cardiac fibroblasts were isolated from 1- to 3-day-old Sprague--Dawley rats. Immunofluorescence and Western blot analysis revealed the presence of estrogen receptor-alpha (ER-alpha), and -beta (ER-beta) subtypes, with the ER-alpha subtype localized on the plasma membrane. Likewise, both progesterone receptor-A (PR-A), and -B (PR-B) subtypes were expressed in cardiac fibroblasts, and the PR-B appeared to be the predominant subtype associated with the plasma membrane. Despite the presence of both ER subtypes, the treatment of cardiac fibroblasts with 1 microM 17 beta-estradiol exerted a modest decrease in DNA synthesis. By contrast, progesterone treatment caused a dose-dependent decrease in [3H]thymidine uptake, without a concomitant induction of apoptosis. The progesterone-mediated decrease in DNA synthesis was associated with the upregulation of the cyclin-dependent kinase inhibitor p27(Kip1), whereas p21(cip) and proliferating cell nuclear antigen protein levels were unchanged. Lastly, despite the modest effect on DNA synthesis, 17 beta-estradiol increased the steady-state mRNA levels of transforming growth factor-beta(3) and fibronectin. Likewise, progesterone increased the expression of both transforming growth factor-beta(3), and fibronectin mRNA.
CONCLUSION: Collectively, these data are the first to highlight the presence of estrogen and progesterone receptor subtypes on the plasma membrane of neonatal rat cardiac fibroblasts, and further underscore the ability of ovarian hormones to directly suppress DNA synthesis, and influence putative molecular events associated with extracellular matrix remodeling.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11861043     DOI: 10.1016/s0008-6363(01)00525-9

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  9 in total

1.  Effects of elevated glucose levels on interactions of cardiac fibroblasts with the extracellular matrix.

Authors:  Xiaoyi Zhang; James A Stewart; Ian D Kane; Erin P Massey; Dawn O Cashatt; Wayne E Carver
Journal:  In Vitro Cell Dev Biol Anim       Date:  2007-09-12       Impact factor: 2.416

Review 2.  Connecting sex differences, estrogen signaling, and microRNAs in cardiac fibrosis.

Authors:  Lejla Medzikovic; Laila Aryan; Mansoureh Eghbali
Journal:  J Mol Med (Berl)       Date:  2019-08-26       Impact factor: 4.599

3.  Inhibition of angiotensin II induced endothelin-1 gene expression by 17-beta-oestradiol in rat cardiac fibroblasts.

Authors:  H-H Chao; J-J Chen; C-H Chen; H Lin; C-F Cheng; W-S Lian; Y-L Chen; S-H Juan; J-C Liu; J-Y Liou; P Chan; T-H Cheng
Journal:  Heart       Date:  2005-05       Impact factor: 5.994

4.  Effects of testosterone, estrogen and progesterone on TNF-α mediated cellular damage in rat arthritic synovial fibroblasts.

Authors:  Kalaivani Ganesan; Chidambaram Balachandran; Bhakthavatsalam Murali Manohar; Rengarajulu Puvanakrishnan
Journal:  Rheumatol Int       Date:  2011-09-30       Impact factor: 2.631

Review 5.  Sex steroids and stem cell function.

Authors:  Rinki Ray; Nathan M Novotny; Paul R Crisostomo; Tim Lahm; Aaron Abarbanell; Daniel R Meldrum
Journal:  Mol Med       Date:  2008 Jul-Aug       Impact factor: 6.354

6.  Sex-specific modification of progesterone receptor expression by 17β-oestradiol in human cardiac tissues.

Authors:  Georgios Kararigas; Eva Becher; Shokoufeh Mahmoodzadeh; Christoph Knosalla; Roland Hetzer; Vera Regitz-Zagrosek
Journal:  Biol Sex Differ       Date:  2010-11-04       Impact factor: 5.027

7.  Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-β1 and HIF-1α in Ang II-mediated fibrosis after myocardial infarction.

Authors:  Xizhong Sui; Hongchao Wei; Dacheng Wang
Journal:  J Cell Mol Med       Date:  2015-03-30       Impact factor: 5.310

8.  Estradiol promotes the development of a fibrotic phenotype and is increased in the serum of patients with systemic sclerosis.

Authors:  Keiko Aida-Yasuoka; Christine Peoples; Hidekata Yasuoka; Pamela Hershberger; Katelynn Thiel; Jane A Cauley; Thomas A Medsger; Carol A Feghali-Bostwick
Journal:  Arthritis Res Ther       Date:  2013-01-10       Impact factor: 5.156

9.  Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments.

Authors:  Kristina Yeghiazaryan; Dirk Skowasch; Gerhard Bauriedel; Hans H Schild; Olga Golubnitschaja
Journal:  EPMA J       Date:  2011-04-03       Impact factor: 6.543

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.